Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.


Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Bearish
4
Neutral
9
Bullish
1
Bearish
29
Neutral
13
Bullish
4
Bearish
25
Neutral
4
Bullish
3
Pharmaceuticals
Pharmaceuticals - Indian - Bulk Drugs & Formln M/S
42 Cr
Low Risk
17.8
30.8
0.3
2.5
53.30
37.70
Sales CAGR
1Y
14.78%
3Y
31.01%
5Y
29.20%
10Y
—
Profit CAGR
1Y
43.59%
3Y
59.38%
5Y
69.27%
10Y
—
ROE
TTM
13.13%
3Y
7.81%
5Y
6.61%
10Y
—
ROCE
TTM
15.92%
3Y
12.33%
5Y
10.17%
10Y
—
Performance
STEADY PERFORMER
Valuation
REASONABLE
Growth
STABLE
Profitability
HIGH MARGIN
Technicals
Bearish
Risk
MODERATE RISK
Market Cap
₹ 42 Cr
P/E
17.84